Aquestive Therapeutics (AQST) Net Cash Flow Growth (1y) (2018 - 2026)
Aquestive Therapeutics (AQST) Net Cash Flow Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn | 112.26% |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn | -44.11% |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn | -236.85% |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn | -1,047.81% |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn | -1,020.00% |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn | -807.00% |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn | 444.33% |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn | -107.45% |
| 10 | Aquestive Therapeutics | 487.99 Mn | 377.25 Mn | 10.98 Mn | -261.20% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -261.20% |
| Dec 31, 2025 | -24.37% |
| Sep 30, 2025 | 672.15% |
| Jun 30, 2025 | -52.36% |
| Mar 31, 2025 | -104.05% |
| Dec 31, 2024 | -507.37% |
| Sep 30, 2024 | -582.75% |
| Jun 30, 2024 | -19.88% |
| Mar 31, 2024 | 18,342.46% |
| Dec 31, 2023 | -112.12% |
| Sep 30, 2023 | 160.06% |
| Jun 30, 2023 | -250.25% |
| Mar 31, 2023 | 97.06% |
| Dec 31, 2022 | 374.65% |
| Sep 30, 2022 | 131.07% |
| Jun 30, 2022 | -56.07% |
| Mar 31, 2022 | -208.38% |
| Dec 31, 2021 | -121.30% |
| Sep 30, 2021 | 63.27% |
| Jun 30, 2021 | 166.70% |